National Immunoglobulin Treatment Survey

Your feedback is valuable! 

By participating in the 2024 National Immunoglobulin (Ig) Treatment Survey, you can share your experiences with intravenous, subcutaneous, and intramuscular Ig replacement therapy. Your firsthand experiences will help us further define the characteristics of patients who receive Ig therapy and provide valuable information to healthcare and research communities that can improve the quality of care of individuals living with PI.  

Requirements to receive the survey:

• You must be over the age of 18 years old.
• You must live in the United States.
• You or your child, who is under the age of 18, must be affected by primary immunodeficiency (PI). 
   

Questions? Contact the Immune Deficiency Foundations Vice President of Research, Christopher Scalchunes, at cscalchunes@primaryimmune.org.